Datopotamab deruxtecan (Dato-DXd) plus rilvegostomig (rilve) in patients (pts) with locally advanced or metastatic urothelial cancer (a/mUC): Results from the phase II TROPION-PanTumor03 study
Rha, S. Y.;
Lim, S. H.;
Zhou, F.;
Jung, K. H.;
Wysocki, P. J.;
외 14명
Citations
WEB OF SCIENCE
0
제목
Datopotamab deruxtecan (Dato-DXd) plus rilvegostomig (rilve) in patients (pts) with locally advanced or metastatic urothelial cancer (a/mUC): Results from the phase II TROPION-PanTumor03 study
저자
Rha, S. Y.; Lim, S. H.; Zhou, F.; Jung, K. H.; Wysocki, P. J.; Drosik-Rutowicz, K.; Chen, J-s.; Taniguchi, H.; Urun, Y.; Harano, K.; Siena, S.; Lin, C-c.; Chung, C-f.; Barrera, R. Morales; Gajavelli, S.; Kulkarni, D.; Gharagoozloo, S.; Janjigian, Y. Y.; Meric-Bernstam, F.